These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 527341)

  • 1. A comparative study of the effect of the Progestasert TM and Gravigard IUDs on dysmenorrhoea.
    Pizarro E; Gomez-Rogers C; Rowe PJ
    Contraception; 1979 Nov; 20(5):455-66. PubMed ID: 527341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability].
    Custo GM; Cosmi EV
    Patol Clin Ostet Ginecol; 1984; 12(4):331-43. PubMed ID: 12340352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical performance of the TCu 380A and Lippes Loop IUDs in three developing countries.
    Farr G; Amatya R; Acosta M; Ekwempu C; Kisninci H
    Contraception; 1995 Jul; 52(1):17-22. PubMed ID: 8521710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum cortisol level in lactating women using Progestasert system.
    Askalani H; Badraoui MH; Mahrous T; Osman MI; Bayad MA; Ibrahim II; Abdalla MI
    Popul Sci; 1981; (2):109-14. PubMed ID: 12339476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mefenamic acid for dysmenorrhea in patients with intrauterine devices.
    Budoff PW
    JAMA; 1979 Aug; 242(7):616-7. PubMed ID: 448996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum prolactin levels in lactating women using progestasert system.
    Badraoui MH; Askalani H; Mahrous I; Osman MI; Bayad MA; Ibrahim II; Abdalla MT
    Popul Sci; 1981; (2):115-20. PubMed ID: 12339477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Menstrual blood loss and body iron stores: comparative study between a Multiload-375 IUD and a levonorgestrel vaginal ring].
    Souza JP; Andrade AT; Pizarro E
    Bol Cent Biol Reprod; 1991; 10(1):26-32. PubMed ID: 12318141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary report on a postpartum CuT 200 study, Santiago, Chile.
    Lavin P; Waszak C; Bravo C
    Int J Gynaecol Obstet; 1983 Feb; 21(1):71-5. PubMed ID: 6133798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between two IUDs: Progestasert and CuT 200.
    Larsen S; Hansen MK; Jacobsen JC; Ladehoff P; Sorensen T; Westergaard JG
    Contracept Deliv Syst; 1981 Oct; 2(4):281-6. PubMed ID: 12336988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in intrauterine devices.
    Farr G
    Netw Res Triangle Park N C; 1991 Sep; 12(2):9. PubMed ID: 12284281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for copper T IUD expulsion: an epidemiologic analysis.
    Zhang J; Feldblum PJ; Chi IC; Farr MG
    Contraception; 1992 Nov; 46(5):427-33. PubMed ID: 1458889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative studies on menstrual blood loss in IUD users.
    Andrade AT; Pizarro Orchard E
    Contraception; 1987 Jul; 36(1):129-44. PubMed ID: 3311622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of T Cu 200 and Progestasert IUDs.
    Lavin P; Bravo C; Waszak C
    Contracept Deliv Syst; 1983 Apr; 4(2):143-7. PubMed ID: 12338635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A collaborative study of the progesterone intrauterine device (Progestasert). The World Health Organization Task Force on Methods for the Regulation of Implantation.
    Newton J; Szontagh F; Lebech P; Rowe P
    Contraception; 1979 Jun; 19(6):575-89. PubMed ID: 487808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selected events following insertion of the Progestasert system.
    Gibor Y; Mitchell C
    Contraception; 1980 May; 21(5):491-503. PubMed ID: 7428359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of the IUD insertion.
    Edelman DA; Zipper J; Rivera M; Medel M
    Contraception; 1979 May; 19(5):449-54. PubMed ID: 467054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of laparoscopic sterilization and insertion of Multiload Cu 250 and Progestasert IUDs on serum ferritin levels.
    Goh TH; Hariharan M
    Contraception; 1983 Oct; 28(4):329-36. PubMed ID: 6667621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hysterographic orientation of IUDs in relation to menstrual blood loss.
    Kandil O; Aref I; El-sheikha Z; Radwan MM; El-agizi H; Hassanein MK
    Contracept Deliv Syst; 1983 Jul; 4(3):213-7. PubMed ID: 12265365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.